Nivolumab for Recurrent/Metastatic Carcinosarcoma

Clinical trial NCT05224999 · UNKNOWN

Trial details

NCT number: NCT05224999
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent/Metastatic Carcinosarcoma

Start date: 2019-11-13
Primary completion: 2023-01-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.